Michele Bartoletti

Tocilizumab in patients with severe COVID-19: a retrospective cohort study

Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi‐Lepri et al. · The Lancet Rheumatology · 2020 · 997 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +6

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Infections caused by KPC-producing <i>Klebsiella pneumoniae</i> : differences in therapy and mortality in a multicentre study

Mario Tumbarello, Enrico Maria Trecarichi, Francesco Giuseppe De Rosa et al. · Journal of Antimicrobial Chemotherapy · 2015 · 512 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

Salvatore Piano, Virendra Singh, Paolo Caraceni et al. · Gastroenterology · 2018 · 501 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14